PALMIVAX
PALMIVAX
Authorised
- Water for injection
- Derzsy's disease virus, strain H, Live
Product identification
Medicine name:
PALMIVAX
Active substance:
- Water for injection
- Derzsy's disease virus, strain H, Live
Target species:
-
Duck
-
Goose
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Water for injection0.50/millilitre(s)0.50millilitre(s)
-
Derzsy's disease virus, strain H, Live316.23/cell culture infective dose 500.50millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Duck
-
All relevant tissues0day
-
-
Goose
-
All relevant tissues0day
-
-
-
Subcutaneous use
-
Duck
-
All relevant tissues0day
-
-
Goose
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01DD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/0393979 4/1982
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
